← 產業報告目錄
Microbial Therapeutic Product Industry Research Report 2026
出版商 APO Research產業別 Healthcare & Life Sciences出版日期 2026-01-02頁數 133報告編號 APO-96457d7a6b
授權報價
| Single User | $2,950 USD |
| Multi User | $4,430 USD |
| Enterprise | $5,900 USD |
報告摘要
The global Microbial Therapeutic Product market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Microbial Therapeutic Product market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Microbial Therapeutic Product market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Microbial Therapeutic Product market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Microbial Therapeutic Product include Novartis, Roche, Eli Lilly and Company, Pfizer, Amgen Inc., Viatris, Sanofi S.A., Novo Nordisk A/S and Merck & Co. Inc., among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Microbial Therapeutic Product market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Microbial Therapeutic Product.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Microbial Therapeutic Product Market by Company
Novartis
Roche
Eli Lilly and Company
Pfizer
Amgen Inc.
Viatris
Sanofi S.A.
Novo Nordisk A/S
Merck & Co. Inc.
Intas Pharmaceuticals Ltd.
Dr. Reddy’s Laboratories Ltd.
Bristol-Myers Squibb Company
Boehringer Ingelheim
Biocon
Abbot Laboratories
Microbial Therapeutic Product Segment by Type
Single Use Pre-Filled Injection/Injector Pen
Multi-use Injectors
Others
Microbial Therapeutic Product Segment by Application
Oncology
Haematological Disorders
Immunological Disorders
Allergic Diseases
Metabolic Disorders
Infectious Diseases
Others
Microbial Therapeutic Product Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Microbial Therapeutic Product market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Microbial Therapeutic Product and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Microbial Therapeutic Product.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Microbial Therapeutic Product companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
目錄 Table of Contents
1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Microbial Therapeutic Product by Type
2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
2.2.2 Single Use Pre-Filled Injection/Injector Pen
2.2.3 Multi-use Injectors
2.2.4 Others
2.3 Microbial Therapeutic Product by Application
2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
2.3.2 Oncology
2.3.3 Haematological Disorders
2.3.4 Immunological Disorders
2.3.5 Allergic Diseases
2.3.6 Metabolic Disorders
2.3.7 Infectious Diseases
2.3.8 Others
2.4 Assumptions and Limitations
3 Microbial Therapeutic Product Breakdown Data by Type
3.1 Global Microbial Therapeutic Product Historic Market Size by Type (2021-2026)
3.2 Global Microbial Therapeutic Product Forecasted Market Size by Type (2027-2032)
4 Microbial Therapeutic Product Breakdown Data by Application
4.1 Global Microbial Therapeutic Product Historic Market Size by Application (2021-2026)
4.2 Global Microbial Therapeutic Product Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
5.1 Global Microbial Therapeutic Product Market Perspective (2021-2032)
5.2 Global Microbial Therapeutic Product Growth Trends by Region
5.2.1 Global Microbial Therapeutic Product Market Size by Region: 2021 VS 2025 VS 2032
5.2.2 Microbial Therapeutic Product Historic Market Size by Region (2021-2026)
5.2.3 Microbial Therapeutic Product Forecasted Market Size by Region (2027-2032)
5.3 Microbial Therapeutic Product Market Dynamics
5.3.1 Microbial Therapeutic Product Industry Trends
5.3.2 Microbial Therapeutic Product Market Drivers
5.3.3 Microbial Therapeutic Product Market Challenges
5.3.4 Microbial Therapeutic Product Market Restraints
6 Market Competitive Landscape by Players
6.1 Global Top Microbial Therapeutic Product Players by Revenue
6.1.1 Global Top Microbial Therapeutic Product Players by Revenue (2021-2026)
6.1.2 Global Microbial Therapeutic Product Revenue Market Share by Players (2021-2026)
6.2 Global Microbial Therapeutic Product Industry Players Ranking, 2023 VS 2024 VS 2025
6.3 Global Key Players of Microbial Therapeutic Product Head Office and Area Served
6.4 Global Microbial Therapeutic Product Players, Product Type & Application
6.5 Global Microbial Therapeutic Product Manufacturers Established Date
6.6 Global Microbial Therapeutic Product Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 North America
7.1 North America Microbial Therapeutic Product Market Size (2021-2032)
7.2 North America Microbial Therapeutic Product Market Growth Rate by Country: 2021 VS 2025 VS 2032
7.3 North America Microbial Therapeutic Product Market Size by Country (2021-2026)
7.4 North America Microbial Therapeutic Product Market Size by Country (2027-2032)
7.5 United States
7.5 United States
7.6 Canada
7.7 Mexico
8 Europe
8.1 Europe Microbial Therapeutic Product Market Size (2021-2032)
8.2 Europe Microbial Therapeutic Product Market Growth Rate by Country: 2021 VS 2025 VS 2032
8.3 Europe Microbial Therapeutic Product Market Size by Country (2021-2026)
8.4 Europe Microbial Therapeutic Product Market Size by Country (2027-2032)
8.5 Germany
8.6 France
8.7 U.K.
8.8 Italy
8.9 Spain
8.10 Russia
8.11 Netherlands
8.12 Nordic Countries
9 Asia-Pacific
9.1 Asia-Pacific Microbial Therapeutic Product Market Size (2021-2032)
9.2 Asia-Pacific Microbial Therapeutic Product Market Growth Rate by Country: 2021 VS 2025 VS 2032
9.3 Asia-Pacific Microbial Therapeutic Product Market Size by Country (2021-2026)
9.4 Asia-Pacific Microbial Therapeutic Product Market Size by Country (2027-2032)
9.5 China
9.6 Japan
9.7 South Korea
9.8 India
9.9 Australia
9.10 China Taiwan
9.11 Southeast Asia
10 South America
10.1 South America Microbial Therapeutic Product Market Size (2021-2032)
10.2 South America Microbial Therapeutic Product Market Growth Rate by Country: 2021 VS 2025 VS 2032
10.3 South America Microbial Therapeutic Product Market Size by Country (2021-2026)
10.4 South America Microbial Therapeutic Product Market Size by Country (2027-2032)
10.5 Brazil
10.6 Argentina
10.7 Chile
10.8 Colombia
10.9 Peru
11 Middle East & Africa
11.1 Middle East & Africa Microbial Therapeutic Product Market Size (2021-2032)
11.2 Middle East & Africa Microbial Therapeutic Product Market Growth Rate by Country: 2021 VS 2025 VS 2032
11.3 Middle East & Africa Microbial Therapeutic Product Market Size by Country (2021-2026)
11.4 Middle East & Africa Microbial Therapeutic Product Market Size by Country (2027-2032)
11.5 Saudi Arabia
11.6 Israel
11.7 United Arab Emirates
11.8 Turkey
11.9 Iran
11.10 Egypt
12 Players Profiled
12.1 Novartis
12.1.1 Novartis Company Information
12.1.2 Novartis Business Overview
12.1.3 Novartis Revenue in Microbial Therapeutic Product Business (2021-2026)
12.1.4 Novartis Microbial Therapeutic Product Product Portfolio
12.1.5 Novartis Recent Developments
12.2 Roche
12.2.1 Roche Company Information
12.2.2 Roche Business Overview
12.2.3 Roche Revenue in Microbial Therapeutic Product Business (2021-2026)
12.2.4 Roche Microbial Therapeutic Product Product Portfolio
12.2.5 Roche Recent Developments
12.3 Eli Lilly and Company
12.3.1 Eli Lilly and Company Company Information
12.3.2 Eli Lilly and Company Business Overview
12.3.3 Eli Lilly and Company Revenue in Microbial Therapeutic Product Business (2021-2026)
12.3.4 Eli Lilly and Company Microbial Therapeutic Product Product Portfolio
12.3.5 Eli Lilly and Company Recent Developments
12.4 Pfizer
12.4.1 Pfizer Company Information
12.4.2 Pfizer Business Overview
12.4.3 Pfizer Revenue in Microbial Therapeutic Product Business (2021-2026)
12.4.4 Pfizer Microbial Therapeutic Product Product Portfolio
12.4.5 Pfizer Recent Developments
12.5 Amgen Inc.
12.5.1 Amgen Inc. Company Information
12.5.2 Amgen Inc. Business Overview
12.5.3 Amgen Inc. Revenue in Microbial Therapeutic Product Business (2021-2026)
12.5.4 Amgen Inc. Microbial Therapeutic Product Product Portfolio
12.5.5 Amgen Inc. Recent Developments
12.6 Viatris
12.6.1 Viatris Company Information
12.6.2 Viatris Business Overview
12.6.3 Viatris Revenue in Microbial Therapeutic Product Business (2021-2026)
12.6.4 Viatris Microbial Therapeutic Product Product Portfolio
12.6.5 Viatris Recent Developments
12.7 Sanofi S.A.
12.7.1 Sanofi S.A. Company Information
12.7.2 Sanofi S.A. Business Overview
12.7.3 Sanofi S.A. Revenue in Microbial Therapeutic Product Business (2021-2026)
12.7.4 Sanofi S.A. Microbial Therapeutic Product Product Portfolio
12.7.5 Sanofi S.A. Recent Developments
12.8 Novo Nordisk A/S
12.8.1 Novo Nordisk A/S Company Information
12.8.2 Novo Nordisk A/S Business Overview
12.8.3 Novo Nordisk A/S Revenue in Microbial Therapeutic Product Business (2021-2026)
12.8.4 Novo Nordisk A/S Microbial Therapeutic Product Product Portfolio
12.8.5 Novo Nordisk A/S Recent Developments
12.9 Merck & Co. Inc.
12.9.1 Merck & Co. Inc. Company Information
12.9.2 Merck & Co. Inc. Business Overview
12.9.3 Merck & Co. Inc. Revenue in Microbial Therapeutic Product Business (2021-2026)
12.9.4 Merck & Co. Inc. Microbial Therapeutic Product Product Portfolio
12.9.5 Merck & Co. Inc. Recent Developments
12.10 Intas Pharmaceuticals Ltd.
12.10.1 Intas Pharmaceuticals Ltd. Company Information
12.10.2 Intas Pharmaceuticals Ltd. Business Overview
12.10.3 Intas Pharmaceuticals Ltd. Revenue in Microbial Therapeutic Product Business (2021-2026)
12.10.4 Intas Pharmaceuticals Ltd. Microbial Therapeutic Product Product Portfolio
12.10.5 Intas Pharmaceuticals Ltd. Recent Developments
12.11 Dr. Reddy’s Laboratories Ltd.
12.11.1 Dr. Reddy’s Laboratories Ltd. Company Information
12.11.2 Dr. Reddy’s Laboratories Ltd. Business Overview
12.11.3 Dr. Reddy’s Laboratories Ltd. Revenue in Microbial Therapeutic Product Business (2021-2026)
12.11.4 Dr. Reddy’s Laboratories Ltd. Microbial Therapeutic Product Product Portfolio
12.11.5 Dr. Reddy’s Laboratories Ltd. Recent Developments
12.12 Bristol-Myers Squibb Company
12.12.1 Bristol-Myers Squibb Company Company Information
12.12.2 Bristol-Myers Squibb Company Business Overview
12.12.3 Bristol-Myers Squibb Company Revenue in Microbial Therapeutic Product Business (2021-2026)
12.12.4 Bristol-Myers Squibb Company Microbial Therapeutic Product Product Portfolio
12.12.5 Bristol-Myers Squibb Company Recent Developments
12.13 Boehringer Ingelheim
12.13.1 Boehringer Ingelheim Company Information
12.13.2 Boehringer Ingelheim Business Overview
12.13.3 Boehringer Ingelheim Revenue in Microbial Therapeutic Product Business (2021-2026)
12.13.4 Boehringer Ingelheim Microbial Therapeutic Product Product Portfolio
12.13.5 Boehringer Ingelheim Recent Developments
12.14 Biocon
12.14.1 Biocon Company Information
12.14.2 Biocon Business Overview
12.14.3 Biocon Revenue in Microbial Therapeutic Product Business (2021-2026)
12.14.4 Biocon Microbial Therapeutic Product Product Portfolio
12.14.5 Biocon Recent Developments
12.15 Abbot Laboratories
12.15.1 Abbot Laboratories Company Information
12.15.2 Abbot Laboratories Business Overview
12.15.3 Abbot Laboratories Revenue in Microbial Therapeutic Product Business (2021-2026)
12.15.4 Abbot Laboratories Microbial Therapeutic Product Product Portfolio
12.15.5 Abbot Laboratories Recent Developments
13 Report Conclusion
14 Disclaimer
圖表清單 List of Tables & Figures
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
Table 5. Global Microbial Therapeutic Product Market Size by Type (2021-2026) & (US$ Million)
Table 6. Global Microbial Therapeutic Product Revenue Market Share by Type (2021-2026)
Table 7. Global Microbial Therapeutic Product Forecasted Market Size by Type (2027-2032) & (US$ Million)
Table 8. Global Microbial Therapeutic Product Revenue Market Share by Type (2027-2032)
Table 9. Global Microbial Therapeutic Product Market Size by Application (2021-2026) & (US$ Million)
Table 10. Global Microbial Therapeutic Product Revenue Market Share by Application (2021-2026)
Table 11. Global Microbial Therapeutic Product Forecasted Market Size by Application (2027-2032) & (US$ Million)
Table 12. Global Microbial Therapeutic Product Revenue Market Share by Application (2027-2032)
Table 13. Global Microbial Therapeutic Product Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Table 14. Global Microbial Therapeutic Product Market Size by Region (2021-2026) & (US$ Million)
Table 15. Global Microbial Therapeutic Product Market Share by Region (2021-2026)
Table 16. Global Microbial Therapeutic Product Forecasted Market Size by Region (2027-2032) & (US$ Million)
Table 17. Global Microbial Therapeutic Product Market Share by Region (2027-2032)
Table 18. Microbial Therapeutic Product Industry Trends
Table 19. Microbial Therapeutic Product Industry Drivers
Table 20. Microbial Therapeutic Product Industry Opportunities and Challenges
Table 21. Microbial Therapeutic Product Market Restraints
Table 22. Global Top Microbial Therapeutic Product Players by Revenue (US$ Million) & (2021-2026)
Table 23. Global Microbial Therapeutic Product Revenue Market Share by Players (2021-2026)
Table 24. Global Microbial Therapeutic Product Industry Players Ranking, 2024 VS 2025 VS 2026
Table 25. Global Key Players of Microbial Therapeutic Product, Headquarters and Area Served
Table 26. Global Microbial Therapeutic Product Players, Product Type & Application
Table 27. Global Players Market Concentration Ratio (CR5 and HHI)
Table 28. Global Microbial Therapeutic Product by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025)
Table 29. Players Mergers & Acquisitions, Expansion Plans
Table 30. North America Microbial Therapeutic Product Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 31. North America Microbial Therapeutic Product Market Size by Country (2021-2026) & (US$ Million)
Table 32. North America Microbial Therapeutic Product Market Size by Country (2027-2032) & (US$ Million)
Table 33. Europe Microbial Therapeutic Product Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 34. Europe Microbial Therapeutic Product Market Size by Country (2021-2026) & (US$ Million)
Table 35. Europe Microbial Therapeutic Product Market Size by Country (2027-2032) & (US$ Million)
Table 36. Asia Pacific Microbial Therapeutic Product Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 37. Asia Pacific Microbial Therapeutic Product Market Size by Region (2021-2026) & (US$ Million)
Table 38. Asia Pacific Microbial Therapeutic Product Market Size by Country (2027-2032) & (US$ Million)
Table 39. South America Microbial Therapeutic Product Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 40. South America Microbial Therapeutic Product Market Size by Country (2021-2026) & (US$ Million)
Table 41. South America Microbial Therapeutic Product Market Size by Country (2027-2032) & (US$ Million)
Table 42. Middle East & Africa Microbial Therapeutic Product Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 43. Middle East & Africa Microbial Therapeutic Product Market Size by Country (2021-2026) & (US$ Million)
Table 44. Middle East & Africa Microbial Therapeutic Product Market Size by Country (2027-2032) & (US$ Million)
Table 45. Novartis Company Information
Table 46. Novartis Business Overview
Table 47. Novartis Revenue in Microbial Therapeutic Product Business (2021-2026) & (US$ Million)
Table 48. Novartis Microbial Therapeutic Product Product Portfolio
Table 49. Novartis Recent Developments
Table 50. Roche Company Information
Table 51. Roche Business Overview
Table 52. Roche Revenue in Microbial Therapeutic Product Business (2021-2026) & (US$ Million)
Table 53. Roche Microbial Therapeutic Product Product Portfolio
Table 54. Roche Recent Developments
Table 55. Eli Lilly and Company Company Information
Table 56. Eli Lilly and Company Business Overview
Table 57. Eli Lilly and Company Revenue in Microbial Therapeutic Product Business (2021-2026) & (US$ Million)
Table 58. Eli Lilly and Company Microbial Therapeutic Product Product Portfolio
Table 59. Eli Lilly and Company Recent Developments
Table 60. Pfizer Company Information
Table 61. Pfizer Business Overview
Table 62. Pfizer Revenue in Microbial Therapeutic Product Business (2021-2026) & (US$ Million)
Table 63. Pfizer Microbial Therapeutic Product Product Portfolio
Table 64. Pfizer Recent Developments
Table 65. Amgen Inc. Company Information
Table 66. Amgen Inc. Business Overview
Table 67. Amgen Inc. Revenue in Microbial Therapeutic Product Business (2021-2026) & (US$ Million)
Table 68. Amgen Inc. Microbial Therapeutic Product Product Portfolio
Table 69. Amgen Inc. Recent Developments
Table 70. Viatris Company Information
Table 71. Viatris Business Overview
Table 72. Viatris Revenue in Microbial Therapeutic Product Business (2021-2026) & (US$ Million)
Table 73. Viatris Microbial Therapeutic Product Product Portfolio
Table 74. Viatris Recent Developments
Table 75. Sanofi S.A. Company Information
Table 76. Sanofi S.A. Business Overview
Table 77. Sanofi S.A. Revenue in Microbial Therapeutic Product Business (2021-2026) & (US$ Million)
Table 78. Sanofi S.A. Microbial Therapeutic Product Product Portfolio
Table 79. Sanofi S.A. Recent Developments
Table 80. Novo Nordisk A/S Company Information
Table 81. Novo Nordisk A/S Business Overview
Table 82. Novo Nordisk A/S Revenue in Microbial Therapeutic Product Business (2021-2026) & (US$ Million)
Table 83. Novo Nordisk A/S Microbial Therapeutic Product Product Portfolio
Table 84. Novo Nordisk A/S Recent Developments
Table 85. Merck & Co. Inc. Company Information
Table 86. Merck & Co. Inc. Business Overview
Table 87. Merck & Co. Inc. Revenue in Microbial Therapeutic Product Business (2021-2026) & (US$ Million)
Table 88. Merck & Co. Inc. Microbial Therapeutic Product Product Portfolio
Table 89. Merck & Co. Inc. Recent Developments
Table 90. Intas Pharmaceuticals Ltd. Company Information
Table 91. Intas Pharmaceuticals Ltd. Business Overview
Table 92. Intas Pharmaceuticals Ltd. Revenue in Microbial Therapeutic Product Business (2021-2026) & (US$ Million)
Table 93. Intas Pharmaceuticals Ltd. Microbial Therapeutic Product Product Portfolio
Table 94. Intas Pharmaceuticals Ltd. Recent Developments
Table 95. Dr. Reddy’s Laboratories Ltd. Company Information
Table 96. Dr. Reddy’s Laboratories Ltd. Business Overview
Table 97. Dr. Reddy’s Laboratories Ltd. Revenue in Microbial Therapeutic Product Business (2021-2026) & (US$ Million)
Table 98. Dr. Reddy’s Laboratories Ltd. Microbial Therapeutic Product Product Portfolio
Table 99. Dr. Reddy’s Laboratories Ltd. Recent Developments
Table 100. Bristol-Myers Squibb Company Company Information
Table 101. Bristol-Myers Squibb Company Business Overview
Table 102. Bristol-Myers Squibb Company Revenue in Microbial Therapeutic Product Business (2021-2026) & (US$ Million)
Table 103. Bristol-Myers Squibb Company Microbial Therapeutic Product Product Portfolio
Table 104. Bristol-Myers Squibb Company Recent Developments
Table 105. Boehringer Ingelheim Company Information
Table 106. Boehringer Ingelheim Business Overview
Table 107. Boehringer Ingelheim Revenue in Microbial Therapeutic Product Business (2021-2026) & (US$ Million)
Table 108. Boehringer Ingelheim Microbial Therapeutic Product Product Portfolio
Table 109. Boehringer Ingelheim Recent Developments
Table 110. Biocon Company Information
Table 111. Biocon Business Overview
Table 112. Biocon Revenue in Microbial Therapeutic Product Business (2021-2026) & (US$ Million)
Table 113. Biocon Microbial Therapeutic Product Product Portfolio
Table 114. Biocon Recent Developments
Table 115. Abbot Laboratories Company Information
Table 116. Abbot Laboratories Business Overview
Table 117. Abbot Laboratories Revenue in Microbial Therapeutic Product Business (2021-2026) & (US$ Million)
Table 118. Abbot Laboratories Microbial Therapeutic Product Product Portfolio
Table 119. Abbot Laboratories Recent Developments
Table 120. Authors List of This Report
List of Figures
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Microbial Therapeutic Product Product Image
Figure 5. Global Microbial Therapeutic Product Market Size Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
Figure 6. Global Microbial Therapeutic Product Market Share by Type: 2025 VS 2032
Figure 7. Single Use Pre-Filled Injection/Injector Pen Product
Figure 8. Multi-use Injectors Product
Figure 9. Others Product
Figure 10. Global Microbial Therapeutic Product Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million)
Figure 11. Global Microbial Therapeutic Product Market Share by Application: 2025 VS 2032
Figure 12. Oncology Product
Figure 13. Haematological Disorders Product
Figure 14. Immunological Disorders Product
Figure 15. Allergic Diseases Product
Figure 16. Metabolic Disorders Product
Figure 17. Infectious Diseases Product
Figure 18. Others Product
Figure 19. Global Microbial Therapeutic Product Market Size (US$ Million), Year-over-Year: 2021-2032
Figure 20. Global Microbial Therapeutic Product Market Size, (US$ Million), 2021 VS 2025 VS 2032
Figure 21. Global Microbial Therapeutic Product Market Share by Region: 2025 VS 2032
Figure 22. Global Microbial Therapeutic Product Market Share by Players in 2025
Figure 23. Global Microbial Therapeutic Product Manufacturers Established Date
Figure 24. Global Top 5 and 10 Microbial Therapeutic Product Players Market Share by Revenue in 2025
Figure 25. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 26. North America Microbial Therapeutic Product Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 27. North America Microbial Therapeutic Product Market Share by Country (2021-2032)
Figure 28. United States Microbial Therapeutic Product Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 29. Canada Microbial Therapeutic Product Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 30. Mexico Microbial Therapeutic Product Market Share by Country (2021-2032)
Figure 31. Europe Microbial Therapeutic Product Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 32. Europe Microbial Therapeutic Product Market Share by Country (2021-2032)
Figure 33. Germany Microbial Therapeutic Product Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 34. France Microbial Therapeutic Product Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 35. U.K. Microbial Therapeutic Product Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 36. Italy Microbial Therapeutic Product Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 37. Spain Microbial Therapeutic Product Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 38. Russia Microbial Therapeutic Product Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 39. Netherlands Microbial Therapeutic Product Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 40. Nordic Countries Microbial Therapeutic Product Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 41. Asia-Pacific Microbial Therapeutic Product Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 42. Asia-Pacific Microbial Therapeutic Product Market Share by Country (2021-2032)
Figure 43. China Microbial Therapeutic Product Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 44. Japan Microbial Therapeutic Product Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 45. South Korea Microbial Therapeutic Product Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 46. India Microbial Therapeutic Product Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 47. India Microbial Therapeutic Product Market Share by Country (2021-2032)
Figure 48. Australia Microbial Therapeutic Product Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 49. China Taiwan Microbial Therapeutic Product Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 50. Southeast Asia Microbial Therapeutic Product Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 51. South America Microbial Therapeutic Product Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 52. South America Microbial Therapeutic Product Market Share by Country (2021-2032)
Figure 53. Brazil Microbial Therapeutic Product Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 54. Argentina Microbial Therapeutic Product Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 55. Chile Microbial Therapeutic Product Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 56. Colombia Microbial Therapeutic Product Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 57. Peru Microbial Therapeutic Product Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 58. Novartis Revenue Growth Rate in Microbial Therapeutic Product Business (2021-2026)
Figure 59. Roche Revenue Growth Rate in Microbial Therapeutic Product Business (2021-2026)
Figure 60. Eli Lilly and Company Revenue Growth Rate in Microbial Therapeutic Product Business (2021-2026)
Figure 61. Pfizer Revenue Growth Rate in Microbial Therapeutic Product Business (2021-2026)
Figure 62. Amgen Inc. Revenue Growth Rate in Microbial Therapeutic Product Business (2021-2026)
Figure 63. Viatris Revenue Growth Rate in Microbial Therapeutic Product Business (2021-2026)
Figure 64. Sanofi S.A. Revenue Growth Rate in Microbial Therapeutic Product Business (2021-2026)
Figure 65. Novo Nordisk A/S Revenue Growth Rate in Microbial Therapeutic Product Business (2021-2026)
Figure 66. Merck & Co. Inc. Revenue Growth Rate in Microbial Therapeutic Product Business (2021-2026)
Figure 67. Intas Pharmaceuticals Ltd. Revenue Growth Rate in Microbial Therapeutic Product Business (2021-2026)
Figure 68. Dr. Reddy’s Laboratories Ltd. Revenue Growth Rate in Microbial Therapeutic Product Business (2021-2026)
Figure 69. Bristol-Myers Squibb Company Revenue Growth Rate in Microbial Therapeutic Product Business (2021-2026)
Figure 70. Boehringer Ingelheim Revenue Growth Rate in Microbial Therapeutic Product Business (2021-2026)
Figure 71. Biocon Revenue Growth Rate in Microbial Therapeutic Product Business (2021-2026)
Figure 72. Abbot Laboratories Revenue Growth Rate in Microbial Therapeutic Product Business (2021-2026)
提及公司
NovartisRocheEli Lilly and CompanyPfizerAmgen Inc.ViatrisSanofi S.A.Novo Nordisk A/SMerck & Co. Inc.Intas Pharmaceuticals Ltd.Dr. Reddy’s Laboratories Ltd.Bristol-Myers Squibb CompanyBoehringer IngelheimBioconAbbot Laboratories
量子訊息有限公司為 APO Research 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們